Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Learn various ways to save money while studying, helping you build your financial skills and enjoy a more manageable budget during college.
27,538 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A BAFTA ceremony moment involving Tourette syndrome sparked a global debate on stigma and language. This report exami...
The world’s hottest stock market dropped about 7% over two trading days as international investors pulled funds, sign...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
Want to decode finance america (foa) earnings? This investor's guide breaks down the numbers, explains what to watch ...
As inflation cools and markets wobble, a quartet of monthly-pay ETFs now offers 6% to 9% yields. This article explain...
Markets are rotating away from AI hype toward real, tangible assets. A small engineering firm is asserting itself wit...
When a major broker raises its bets on a fintech-insurer, investors take notice. This article breaks down the upgrade...
Small-cap healthcare stocks are gaining traction in 2026 as trial milestones and funding flow refresh investor intere...
Two-thirds of the S&P 500 have reported, and the results are surprisingly strong. This could mean smoother gains for ...
XRP sits around $1.40 as institutions quietly expand tokenized-asset settlements on public rails, even as on-chain ac...
Poly Truth launched its presale with a rapid $170,000 in the first 24 hours, signaling strong appetite for an AI back...